Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1137020080190010009
Journal of Gynecologic Oncology
2008 Volume.19 No. 1 p.9 ~ p.16
Expression of MTA1 and nm23-H1 protein in ovarian carcinomas in relation to Lymph node metastasis
Tong Seo-Yun

Kim Yun-Young
Ki Kyung-Do
Lee Jong-Min
Park Yong-Koo
Lee Sun-Kyung
Abstract
Objective : Cancer metastasis is a complex process involving a sequential series of multi-step genetic events, which produces an imbalance between stimulatory and inhibitory genes for metastasis. Presently, we examined the expression of metastatic tumor antigen 1 (MTA1) and nonmetastatic protein 23 homologue H1 (nm23-H1) proteins in metastasized epithelial ovarian cancer cells.

Methods : Fifty-one primary epithelial ovarian tumors and corresponding lymph nodes (LNs) were examined
immunohistochemically for expression of MTA1 and nm23-H1. Expression of these proteins was statistically evaluated.

Results : The frequency of MTA1 expression was 30.3% (10/33) in stage III/IV LNs but was absent (0/18) in stage I/II LNs (p=0.01). MTA1 expression was observed in 50% (6/12) of metastasizing LNs but in only 10.3% (4/39) of
non-metastasizing LNs (p=0.01). In contrast with MTA1, nm23-H1 expression was evident in 16 of 18 (88.9%) stage I/II
ovarian cancer tissue samples but only in 20 of 33 (60.6%) stage III/IV tissues (p=0.05), and nm23-H1 production was
also observed in 75.6% (34/45) of ovarian cancer tissue with residual tumors under 2 cm in diameter, but in 2/6 (33.3%)
of cancer tissue with residual tumors exceeding 2 cm in diameter (p=0.03).

Conclusion : The degree of expression and imbalance of MTA1 and nm23H1 are correlated with ovarian cancer LN metastasis.
KEYWORD
Ovarian neoplasms, Lymphatic metastasis, MTA1, nm23-H1
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø